Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -7.47 | 34.26 |
| PEG Ratio (TTM) | -0.18 | 3.78 |
| P/S Ratio (TTM) | 0.45 | 3.00 |
| P/B Ratio (TTM) | 2.02 | 6.87 |
| P/FCF Ratio (TTM) | 6.34 | 33.52 |
| Price to 5YR AVG Earnings Ratio | N/A | 80.95 |
| Price to 5YR AVG FCF Ratio | N/A | 603.52 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -9.99% | 8.29% |
| ROE (TTM) | -26.60% | 18.99% |
| Net Profit Margin (TTM) | -5.72% | 7.95% |
| ROIC 5YR AVG | N/A | 28.94% |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 16.95% | 140.00% | N/A |
| Revenue | 7.77% | 52.37% | N/A |
| Net Income | 16.92% | 144.22% | N/A |
| Cash Flow | 73.30% | -407.84% | N/A |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.25 | 1.24 |
| Quick Ratio (TTM) | 0.77 | 1.02 |
| D/E Ratio (TTM) | 0.70 | 0.33 |
| Interest Coverage (TTM) | -6.08 | 9.26 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | 2.00 | 4.83 |
| LTL to 5YR AVG FCF | N/A | 42.20 |
| Shares Outstanding Growth 5YR AVG | N/A | 8.05% |